0001593968-21-002312.txt : 20211029 0001593968-21-002312.hdr.sgml : 20211029 20211029201605 ACCESSION NUMBER: 0001593968-21-002312 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210125 FILED AS OF DATE: 20211029 DATE AS OF CHANGE: 20211029 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Waltz Todd CENTRAL INDEX KEY: 0001383895 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36475 FILM NUMBER: 211364936 MAIL ADDRESS: STREET 1: P O BOX 1445 CITY: CUPERTINO STATE: CA ZIP: 95015 FORMER NAME: FORMER CONFORMED NAME: WELTZ TODD DATE OF NAME CHANGE: 20061218 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: AEMETIS, INC CENTRAL INDEX KEY: 0000738214 STANDARD INDUSTRIAL CLASSIFICATION: INDUSTRIAL ORGANIC CHEMICALS [2860] IRS NUMBER: 261407544 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 20400 STEVENS CREEK BLVD STREET 2: SUITE 700 CITY: CUPERTINO STATE: CA ZIP: 95014 BUSINESS PHONE: 408-517-3304 MAIL ADDRESS: STREET 1: 20400 STEVENS CREEK BLVD STREET 2: SUITE 700 CITY: CUPERTINO STATE: CA ZIP: 95014 FORMER COMPANY: FORMER CONFORMED NAME: AE BIOFUELS, INC. DATE OF NAME CHANGE: 20110714 FORMER COMPANY: FORMER CONFORMED NAME: AE Biofuels, Inc. DATE OF NAME CHANGE: 20071212 FORMER COMPANY: FORMER CONFORMED NAME: MARWICH II LTD DATE OF NAME CHANGE: 19840123 4 1 primary_01.xml PRIMARY DOCUMENT X0306 4 2021-01-25 0000738214 AEMETIS, INC AMTX 0001383895 Waltz Todd 20400 STEVENS CREK BLVD, SUITE 700 CUPERTINO CA 95014 false true false false Executive Vice President, CFO Common Stock 2021-01-26 4 S false 10000 9.609 D 165401 D Common Stock 2021-01-25 4 S false 10000 7.1135 D 165401 D Common Stock 2021-01-29 4 S false 10000 6.57 D 165401 D Common Stock 2021-02-01 4 S false 10000 7.91 D 165401 D Common Stock 2021-02-02 4 S false 10000 8 D 165401 D Common Stock 2021-02-03 4 S false 10000 7.53 D 165401 D Common Stock 2021-02-04 4 S false 10000 7.86 D 165401 D Common Stock 2021-02-05 4 S false 10000 7.45 D 165401 D Common Stock 2021-02-08 4 S false 10000 7.59 D 165401 D Common Stock 2021-02-09 4 S false 10000 7.25 D 165401 D Common Stock 2021-02-10 4 S false 10000 7.31 D 165401 D Common Stock 2021-02-11 4 S false 10000 7.71 D 165401 D Common Stock 2021-02-12 4 S false 10000 7.24 D 165401 D Common Stock 2021-02-16 4 S false 10000 7.8 D 165401 D Common Stock 2021-02-17 4 S false 10000 8.8 D 165401 D Common Stock 2021-02-18 4 S false 10000 8.07 D 165401 D Common Stock 2021-02-19 4 S false 10000 8.15 D 165401 D Common Stock 2021-02-22 4 S false 10000 8.27 D 165401 D Common Stock 2021-03-15 4 F false 4955 20.83 D 240446 D Common Stock 2021-03-15 4 S false 26000 19.9231 D 194446 D Common Stock 2021-03-17 4 S false 455 19.5437 D 214840 D Common Stock 2021-03-17 4 F false 5106 18.42 D 215295 D Common Stock 2021-04-19 4 F false 3649 18.99 D 242209 D Common Stock 2021-04-19 4 S false 51170 19.6681 D 191039 D Common Stock 2021-04-22 4 S false 23099 19.3969 D 167940 D Common Stock 2021-01-27 4 S false 10000 7.77 D 165401 D Common Stock 2021-01-28 4 S false 10000 7.5281 D 165401 D Common Stock 2021-03-16 4 S false 29045 19.5437 D 165401 D Common Stock 2021-03-17 4 S false 46900 18.9162 D 167940 D These transactions were incorrectly reported in Table II on prior Form 4s filed by the Reporting Person in connection with the Reporting Persons exercise of stock options and sale of common stock from those issuances. These shares were sold pursuant to a Rule 10b5-1 plan. As of the date of the first reported transaction on this Form 4, the Reporting Person beneficially owned 165,401 shares of the Issuers common stock. Each of the sale and withholding transactions reported herein was with respect to shares received from the exercise of stock options previously described on prior Form 4s. Except in connection with the March 17, 2021 option exercise in which the Reporting Person sold all but 2,539 shares received upon exercise, the transactions reported herein did not result in a net change in the number of shares beneficially owned by the Reporting Person. As of the date of this filing, the Reporting Person beneficially owned 167,940 shares of the Issuers common stock. These shares were withheld by the Issuer in connection with the Reporting Persons exercise of stock options. /s/ Todd Waltz 2021-10-29